Xiaohua Zhou

Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight

This structured narrative review examines how AI-SaMD regulation is moving beyond single-point premarket evaluation toward continuous and dynamic oversight, and synthesizes five evidence dimensions central to ongoing regulatory assurance: data evidence, algorithm evidence, software and cybersecurity evidence, clinical scenario and human factors evidence, and real-world data/real-world evidence with change management.